Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partial neuromuscular blockade to facilitate lung and diaphragm protective ventilation
2018-000748-24Phase 4Active
- Sponsor
- Amsterdam UMC, location VUmc
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rocuronium in airway morbidity, sponsored by Amsterdam UMC, location VUmc. Primary endpoints: Feasibility of lung-protective ventilation and Safety of prolonged partial neuromuscular blockade. Started Jun 2018; status: active.
02
Drugs
rocuronium
03
Conditions
airway morbidity
Beyond the preview
Go deeper on 2018-000748-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000748-24.